News
Celgene Corporation to Webcast at Upcoming Investor Conferences and Events
Celgene Corporation plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company. ...
News
Astellas Announces Abstracts Highlighting Growing Oncology Portfolio to be Presented at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Astellas Pharma Inc announced hat a wide selection of abstracts highlighting the Company's diverse oncology portfolio across a broad range of cancers have been...
Industry Reports
Novartis successfully completes acquisition of AveXis, Inc.
Novartis AG announced that it has completed the acquisition of AveXis, Inc. through the consummation of a merger of its indirect wholly-owned subsidiary, Novartis...
Industry Reports
Lilly to buy cancer drug developer AurKa Pharma
Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound...
Press Releases
Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer Inc. announced the United States FDA approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the...
News
Focus on increased system efficiency in Process Technology
Wieland Thermal Solutions at the ACHEMA 2018, hall 6.1, booth C4.Ulm, May 23rd - From 11th to 15th June the Achema, the World Forum...
Press Releases
Recipharm invests in Brexit preparations
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read